JP2015532096A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015532096A5 JP2015532096A5 JP2015534771A JP2015534771A JP2015532096A5 JP 2015532096 A5 JP2015532096 A5 JP 2015532096A5 JP 2015534771 A JP2015534771 A JP 2015534771A JP 2015534771 A JP2015534771 A JP 2015534771A JP 2015532096 A5 JP2015532096 A5 JP 2015532096A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- aoi
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical group 0.000 claims 20
- 238000000034 method Methods 0.000 claims 15
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- 239000004471 Glycine Substances 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261708554P | 2012-10-01 | 2012-10-01 | |
| US61/708,554 | 2012-10-01 | ||
| PCT/US2013/062410 WO2014055370A1 (en) | 2012-10-01 | 2013-09-27 | Compostions and methods for producing glycoproteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015532096A JP2015532096A (ja) | 2015-11-09 |
| JP2015532096A5 true JP2015532096A5 (OSRAM) | 2016-11-17 |
| JP6351598B2 JP6351598B2 (ja) | 2018-07-04 |
Family
ID=49354940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015534771A Active JP6351598B2 (ja) | 2012-10-01 | 2013-09-27 | 糖タンパク質を産生するための組成物および方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20150259425A1 (OSRAM) |
| EP (1) | EP2904092B1 (OSRAM) |
| JP (1) | JP6351598B2 (OSRAM) |
| KR (1) | KR102182885B1 (OSRAM) |
| CN (1) | CN104797707A (OSRAM) |
| AU (1) | AU2013327681B2 (OSRAM) |
| BR (1) | BR112015007319B1 (OSRAM) |
| CA (1) | CA2886753C (OSRAM) |
| CY (1) | CY1119602T1 (OSRAM) |
| DK (1) | DK2904092T3 (OSRAM) |
| EA (1) | EA201590550A1 (OSRAM) |
| ES (1) | ES2646594T3 (OSRAM) |
| HK (1) | HK1207394A1 (OSRAM) |
| HR (1) | HRP20171753T1 (OSRAM) |
| HU (1) | HUE034896T2 (OSRAM) |
| IL (1) | IL237916A0 (OSRAM) |
| IN (1) | IN2015DN02630A (OSRAM) |
| LT (1) | LT2904092T (OSRAM) |
| ME (1) | ME02882B (OSRAM) |
| MX (1) | MX366106B (OSRAM) |
| NO (1) | NO2760138T3 (OSRAM) |
| PL (1) | PL2904092T3 (OSRAM) |
| PT (1) | PT2904092T (OSRAM) |
| RS (1) | RS56641B1 (OSRAM) |
| SG (2) | SG11201502339YA (OSRAM) |
| SI (1) | SI2904092T1 (OSRAM) |
| SM (1) | SMT201700588T1 (OSRAM) |
| WO (1) | WO2014055370A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10376582B2 (en) | 2013-10-16 | 2019-08-13 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
| WO2016070089A2 (en) * | 2014-10-31 | 2016-05-06 | Abbvie Biotherapeutics Inc. | Anti-cs1 antibodies and antibody drug conjugates |
| WO2016118707A1 (en) | 2015-01-21 | 2016-07-28 | Oncobiologics, Inc. | Modulation of charge variants in a monoclonal antibody composition |
| JP6674028B2 (ja) * | 2016-01-06 | 2020-04-01 | アウトルック セラピューティクス，インコーポレイティド | モノクローナル抗体組成物中のアフコシル化種の調節 |
| EP3400242A1 (en) * | 2016-01-06 | 2018-11-14 | Oncobiologics, Inc. | Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition |
| AU2017213775A1 (en) | 2016-02-03 | 2018-08-16 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
| WO2017146646A1 (en) * | 2016-02-22 | 2017-08-31 | Agency For Science, Technology And Research | Cell culture medium |
| JP7406990B2 (ja) | 2016-11-11 | 2023-12-28 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | ヒト血漿様培地 |
| SG11202009216YA (en) | 2018-03-26 | 2020-10-29 | Amgen Inc | Total afucosylated glycoforms of antibodies produced in cell culture |
| CN112566643A (zh) | 2018-06-12 | 2021-03-26 | 加利福尼亚大学董事会 | 用于治疗癌症的单链双特异性嵌合抗原受体 |
| CR20210521A (es) * | 2019-04-18 | 2022-04-01 | Janssen Biotech Inc | Glicoproteínas saliladas |
| CN111944050B (zh) * | 2020-08-19 | 2022-05-13 | 苏州普乐康医药科技有限公司 | 一种抗b7-h3抗体及其应用 |
| CN113337562B (zh) * | 2021-05-24 | 2022-06-03 | 宁波人健药业集团股份有限公司 | 使用CHO细胞高效发酵生产rhCG的方法 |
| CN113480632B (zh) * | 2021-07-30 | 2023-02-03 | 宁波人健药业集团股份有限公司 | 一种在CHO细胞中表达的重组蛋白rhCG纯化工艺 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4716111A (en) | 1982-08-11 | 1987-12-29 | Trustees Of Boston University | Process for producing human antibodies |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5413923A (en) | 1989-07-25 | 1995-05-09 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| ATE408012T1 (de) | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク． | 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体 |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| US5705364A (en) | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| US5916771A (en) | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| DE69738539T2 (de) | 1996-12-03 | 2009-03-26 | Amgen Fremont Inc. | Vollkommen humane Antikörper die EGFR binden |
| BRPI9809391B8 (pt) | 1997-04-14 | 2021-05-25 | Amgen Res Munich Gmbh | processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| CA2438148A1 (en) * | 2001-02-15 | 2002-08-29 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
| BRPI0509177A (pt) | 2004-03-24 | 2007-09-18 | Pdl Biopharma Inc | uso de anticorpos anti-alfa5beta1 para inibir a proliferação de células cancerìgenas |
| AU2005335714B2 (en) | 2004-11-10 | 2012-07-26 | Macrogenics, Inc. | Engineering Fc antibody regions to confer effector function |
| KR20100053607A (ko) | 2007-08-03 | 2010-05-20 | 패시트 바이오테크 코포레이션 | 항-ｔｗｅａｋ 수용체 항체의 치료 용도 |
-
2012
- 2012-01-12 NO NO14160512A patent/NO2760138T3/no unknown
-
2013
- 2013-09-27 IN IN2630DEN2015 patent/IN2015DN02630A/en unknown
- 2013-09-27 JP JP2015534771A patent/JP6351598B2/ja active Active
- 2013-09-27 LT LTEP13776656.4T patent/LT2904092T/lt unknown
- 2013-09-27 RS RS20171200A patent/RS56641B1/sr unknown
- 2013-09-27 ME MEP-2017-285A patent/ME02882B/me unknown
- 2013-09-27 HK HK15108000.4A patent/HK1207394A1/xx unknown
- 2013-09-27 HU HUE13776656A patent/HUE034896T2/hu unknown
- 2013-09-27 PL PL13776656T patent/PL2904092T3/pl unknown
- 2013-09-27 HR HRP20171753TT patent/HRP20171753T1/hr unknown
- 2013-09-27 ES ES13776656.4T patent/ES2646594T3/es active Active
- 2013-09-27 SM SM20170588T patent/SMT201700588T1/it unknown
- 2013-09-27 EP EP13776656.4A patent/EP2904092B1/en active Active
- 2013-09-27 DK DK13776656.4T patent/DK2904092T3/en active
- 2013-09-27 WO PCT/US2013/062410 patent/WO2014055370A1/en not_active Ceased
- 2013-09-27 BR BR112015007319-0A patent/BR112015007319B1/pt active IP Right Grant
- 2013-09-27 US US14/432,653 patent/US20150259425A1/en not_active Abandoned
- 2013-09-27 PT PT137766564T patent/PT2904092T/pt unknown
- 2013-09-27 KR KR1020157009991A patent/KR102182885B1/ko active Active
- 2013-09-27 EA EA201590550A patent/EA201590550A1/ru unknown
- 2013-09-27 CN CN201380058690.XA patent/CN104797707A/zh active Pending
- 2013-09-27 AU AU2013327681A patent/AU2013327681B2/en active Active
- 2013-09-27 CA CA2886753A patent/CA2886753C/en active Active
- 2013-09-27 SI SI201330877T patent/SI2904092T1/en unknown
- 2013-09-27 SG SG11201502339YA patent/SG11201502339YA/en unknown
- 2013-09-27 SG SG10201702448WA patent/SG10201702448WA/en unknown
- 2013-09-27 MX MX2015004027A patent/MX366106B/es active IP Right Grant
-
2015
- 2015-03-24 IL IL237916A patent/IL237916A0/en unknown
-
2017
- 2017-02-03 US US15/424,672 patent/US20170152540A1/en not_active Abandoned
- 2017-11-14 CY CY20171101192T patent/CY1119602T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015532096A5 (OSRAM) | ||
| HRP20171753T1 (hr) | Pripravci i postupci za proizvodnju glikoproteina | |
| SG10201909806SA (en) | Production of t cell retargeting hetero-dimeric immunoglobulins | |
| EA201900326A1 (ru) | Усовершенствованные способы повышения продуктивности антител в культурах клеток млекопитающих и сведения к минимуму агрегации в процессах выделения и очистки, получения композиций и стабильные композиции антител, полученные этими способами | |
| EP2522724A4 (en) | POLYPEPTIDE MODIFYING METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS | |
| EA201690600A1 (ru) | Метаболически оптимизированная клеточная культура | |
| JP2012143232A5 (OSRAM) | ||
| SG10201810830UA (en) | Cell culture compositions and methods for polypeptide production | |
| JP2013517776A5 (OSRAM) | ||
| BR112015022529A2 (pt) | meios de cultura de células e processos de produção de anticorpo | |
| EA202091422A1 (ru) | Способ непрерывного производства продуктов на основе биспецифических антител | |
| MX2015000683A (es) | Metodo para producir moleculas monomericas y multimericas y uso de las mismas. | |
| EP4477668A3 (en) | Heterodimeric antibody fc-containing proteins and methods for production thereof | |
| NZ596595A (en) | Method for orthopoxvirus production and purification | |
| WO2010013947A3 (ko) | 자연살해세포의 증식방법 | |
| NZ597742A (en) | Method of producing a polypeptide or virus of interest in a continuous cell culture | |
| JP2017508523A5 (OSRAM) | ||
| PL439807A1 (pl) | Sposoby oczyszczania przeciwciał i ich kompozycje | |
| JP2016513478A5 (OSRAM) | ||
| WO2015010118A3 (en) | Transthyretin amyloid-selective and polyreactive catabodies | |
| JP2017520531A5 (OSRAM) | ||
| MY184072A (en) | Increasing virus like particle yield in plants | |
| HRP20231139T1 (hr) | Proizvodnja heteromultimernih proteina upotrebom stanica sisavaca | |
| MX2018004580A (es) | Metodo para producir proteina de fusion con dominio fc de igg. | |
| MX2018015234A (es) | Métodos para mejorar la transformación genética de sorgo. |